Larry Merlo

Business Role

turning CVS Caremark into CVS Health and completing the Aetna acquisition

Business Context

Merlo led CVS through its health-services rebrand and $70B-class Aetna transaction.

Strategic Bets

deepen pharmacy/PBM integration

• remove tobacco
• acquire Aetna
• use stores as health access points

Why the Decisions Matter

CVS is a portfolio of risk, service and retail businesses. Leadership decisions determine capital allocation, insurance pricing, PBM contracts, pharmacy economics, care-delivery growth and enterprise technology. These choices can take years to show results.

Strategic Tension

Aetna created leverage and insurance volatility alongside integration opportunity

Capital Allocation

Leadership balances debt, dividends, insurance capital, technology, pharmacy investment, care delivery and acquisitions. Large health acquisitions can create goodwill/intangible risk if expected margins fail to materialize.

What to Watch

whether Aetna creates enduring enterprise value

Deeper Business Analysis

Merlo oversaw CVS's transformation from pharmacy/PBM into insurer-integrated health company. The Aetna deal gave CVS a new risk-bearing engine but also created the need for insurer underwriting expertise at enterprise scale.

Decision Scorecard

Evaluate leadership through operating outcomes: pricing accuracy, member/client retention, capital return, care quality, debt, free cash flow and whether integrations reduce total friction. Stock price alone is not a sufficient operating scorecard.

From Pharmacy Company to Health Conglomerate

Merlo's strategic arc can be summarized as:

retail pharmacy + PBM
↓
health-services identity
↓
insurance acquisition
↓
fully integrated health-company ambition

The Aetna acquisition was the decisive step.

It changed CVS's exposure from prescription economics into medical-cost underwriting.

Balance-Sheet Consequence

The Aetna transaction required significant financing.

That meant the integration had to deliver enough cash flow and synergy to support debt repayment while CVS continued investment in stores, technology and health services.

Long-Run Test

The deal should be judged on whether Aetna creates durable enterprise advantages through:

• cross-business engagement;
• lower cost;
• better retention;
• better quality;
• differentiated benefits.

Owning an insurer is not itself proof of integration value.